Discover 2,122 paid clinical trials in Allentown, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,122
SLV-154 Treatment of Advanced Cancers
for
Advanced Cancer, Advanced Solid Tumor, Metastatic Cancer
Location: Philadelphia PA, East Brunswick NJ, New York NY,
Sponsor: Solve Therapeutics
Sex: All
Age: 12+
Code: NCT06771219
Phase 1, Recruiting
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Philadelphia PA, Ephrata PA, Lebanon PA, Moorestown NJ,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06616584
Phase 2, Phase 3, Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
for
Neoplasms
Location: Philadelphia PA, Morristown NJ, Hackensack NJ,
Sponsor: Celgene
Sex: All
Age: 0+
Code: NCT03435796
Phase 2, Phase 3, Recruiting
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
for
Solid Tumors, Hematologic Malignancies
Location: Philadelphia PA, New Brunswick NJ, New York NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT03486873
Phase 3, Recruiting
Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma
for
Locally Advanced or Metastatic Melanoma
Location: Philadelphia PA
Sponsor: Fox Chase Cancer Center
Sex: All
Age: 18+
Code: NCT05498792
Early Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
for
Metastatic Castration-resistant Prostate Cancer (mCRPC),
Location: Philadelphia PA, Bala-Cynwyd PA, New Brunswick NJ,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06136650
Phase 3, Recruiting
DMD Voice: Qualitative Interviews With Patients and Caregivers
for
Duchenne Muscular Dystrophy (DMD)
Location: Yardley PA
Sponsor: Red Nucleus Enterprise Solutions, LLC
Sex: Male
Age: 10+
Code: NCT06925269
Recruiting
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Location: Yardley PA, West Chester PA, The Bronx NY, Reston VA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07783802
Phase 2, Recruiting
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
for
Heart Failure
Location: Yardley PA, Bridgewater NJ, New York NY, Baltimore MD,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06935370
Phase 3, Recruiting
New
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
for
Depressive Disorder, Major
Location: West Chester PA, Philadelphia PA, The Bronx NY,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07775300
Phase 3, Recruiting
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
for
Type 2 Diabetes, Cortisol Excess
Location: West Chester PA, Rockville MD, Vienna VA, Albany NY,
Sponsor: Sparrow Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07296484
Phase 2, Recruiting
Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration
for
Age-related Wet Macular Degeneration
Location: Philadelphia PA, Manchester CT, Erie PA, Carmel IN,
Sponsor: Caregen Co. Ltd.
Sex: All
Age: 50+
Code: NCT06132035
Phase 1, Recruiting
The Effect of Medical Management Following Excisional Surgery for Endometriosis: A Randomized Controlled Trial
for
Endometriosis
Location: Wynnewood PA
Sponsor: Main Line Health
Sex: Female
Age: 18+
Code: NCT06439524
Phase 3, Recruiting
Developing an In-vitro Diagnostic Risk-Stratification Test for Oral Cancer
for
Oral Squamous Cell Carcinoma
Location: Wynnewood PA, Warren MI
Sponsor: PeriRx
Sex: All
Age: 18+
Code: NCT01587573
Recruiting
Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System for the Treatment of Calcified Carotid Arteries Prior to Trans-Carotid Stenting (SKYWARD Trans-Carotid IDE [Investigational Device Exemption] Study)